• Molecular NameOuabain
  • SynonymG-Strophanthin; Ouabagenin L-Rhamnoside; Ouabain Octahydrate; Ouabain, Octahydrate; Ouabaine; Strophanthin G; Strophanthin-G
  • Weight584.659
  • Drugbank_IDDB01092
  • ACS_NO630-60-4
  • Show 2D model
  • LogP (experiment)-1.7
  • LogP (predicted, AB/LogP v2.0)-1.62
  • pkaN/A
  • LogD (pH=7, predicted)-1.62
  • Solubility (experiment)13.4 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-3.02
  • LogSw (predicted, AB/LogsW2.0)20.67
  • Sw (mg/ml) (predicted, ACD/Labs)0.56
  • No.of HBond Donors8
  • No.of HBond Acceptors12
  • No.of Rotatable Bonds4
  • TPSA206.6
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA poisonous cardiac glycoside.
  • Absorption_value3.0
  • Absorption (description)N/A
  • Caco_2N/A
  • Bioavailability1.0
  • Protein binding7.5
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life10~20 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicityN/A
  • LD50 (rat)N/A
  • LD50 (mouse)N/A